Empower your cancer research using long-read multiomics
Apply for this SMRT Grant! With highly accurate long reads, known as HiFi reads, you can elevate your research to the next level.
Cancer is an incredibly complex disease and understanding it requires methods that can see the full breadth of cancer genomic variation, from SNVs and indels to SVs, CNVs, and differential methylation. Existing methods can typically capture only a part of this variation, requiring multiple assays and technologies to see the whole picture. Long-read sequencing from PacBio allows cancer researchers to characterize the complete spectrum of somatic and germline DNA variations as well as aberrant splicing and fusion genes at the RNA level.
Tell us in 100 words or less how PacBio HiFi multiomic sequencing data in your project will contribute to understanding cancer and/or developing therapies for a chance to be one of three winners of free sequencing on two Revio SMRT Cell runs.
What HiFi offers for cancer research:
- Genomics: capture all genomic variants including structural variants and repetitive regions, phased into haplotypes
- Epigenomics: Assess 5mC and 6mA methylation directly
- Transcriptomics: Detect RNA isoforms, fusions, and expressed mutations
How to apply
We encourage all scientists of any level to apply! Simply complete the short form on this page and include your 100-word proposal. You can read the official rules or reach out to Camille Conner, Global Lead, Genetic Oncology, about this SMRT Grant. The submission window closes Friday, May 29th, 2026 at 5pm PST.



